- Acheter crypto
- Marchés
- Futures
- Spot
- Copy trading
WE-Launch
US Pharma Company Artelo Announces Launch of Solana Reserve Asset Strategy
BlockBeats News, August 4th, Pharmaceutical company Artelo Biosciences (Nasdaq: ARTL) announced the completion of a $9.475 million off-market private placement, which will be used to launch a Solana (SOL)-centered digital asset reserve strategy, making it the first publicly traded pharmaceutical company to include SOL as a reserve asset.
This private placement includes the issuance of common stock (or pre-funded warrants) at a price of $10.45 per share, as well as two tranches of warrants with exercise prices of $10.20 and $50, respectively, with a three-year term. The transaction is expected to be completed on August 5, 2025.
Vous pourriez aussi aimer
À la hausse
Dernières actus crypto
Analyste BiyaPay: Imminente, la Bourse de Hong Kong accueille le premier géant de la conformité aux cryptomonnaies
Abraxas Capital a alloué la moitié de ses fonds à l'achat de HYPE spot, avec une position atteignant 56 millions de dollars.
BNP Paribas: La Fed continuera à baisser ses taux d'intérêt l'an prochain, place à une nouvelle baisse des rendements obligataires américains
Le Gouvernement du Royaume du Bhoutan a transféré 175,44 EPF, soit environ 49 700 $US.
GIGGLE a retracé les gains d'hier, en reculant d'environ 27% par rapport à son pic.
Assistance client：@weikecs
Collaborations commerciales：@weikecs
Trading quantitatif/Market makers：[email protected]
Programme VIP：[email protected]
App